Breadcrumb

  1. Our vision
  2. About Santen
  3. Santen facts and figures

Santen facts and figures

€2 billion

€2 billion revenue
(approx. 241.6 billion yen)

93% of revenue from prescription ophthalmic pharmaceuticals

93% of revenue from prescription ophthalmic pharmaceuticals 

Overseas sales accounts for 31.7%

Sales outside Japan account for 31.7% of corporate revenue

4,108 employees globally

4,108 employees globally

Products supplied in over 60 countries

Products supplied in over 60 countries 

Dedicated facility for ongoing research and development

Dedicated facilities for ongoing research and development: Nara (Japan), RIKEN-Santen Joint Laboratory (Japan), Santen-SERI OpeN Innovation Center (Singapore), Tampere (Finland), Evry (France), Emeryville (US)

Three manufacturing sites

Three manufacturing sites: Noto and Shiga (Japan), Suzhou (China)

Source: Santen Pharmaceutical Co., Ltd. Fiscal year (FY2019) ended 31 March 2020.